Bivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 5270 participants.
Also called NCT07383155
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 5,270 participants
- Sponsor
- Registry
-
NCT07383155
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07383155. Randomized; no masking; primary purpose treatment. Start 2026-02-01 (anticipated); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Bivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes
- Acronym
- BRIGHT-HBR
- Condition
- Percutaneous Coronary Intervention
- Condition
- High Bleeding Risk
- Condition
- Acute Coronary Syndromes
- Condition
- Anticoagulant Therapy
- Intervention (Drug)
- Anticoagulant Therapy
- Lead sponsor
- Shenyang Northern Hospital
Record details
- Record id
cardio:ct-nct07383155- Content hash
a43049f36a2021ed2ccdc25f6a1430124ad68761ca3190bb8c6b32a1ab753e17